HIV

HIV

Interactive Data Dashboards

Track the HIV & TB response

Live indicators, province breakdowns and downloadable data.

  • With elections and NHI, this is a big year for healthcare in SA

    South Africa is barrelling towards its most consequential and most competitive national and provincial elections since 1994. Spotlight editor Marcus Low asks what is on the line in these elections from a healthcare perspective and argues that the stakes are particularly high when it comes to NHI and the Gauteng and KwaZulu-Natal provincial health departments.

    ·

  • Yogan Pillay | This is how SA can meet its HIV targets

    To respond to the call to end AIDS by 2030, Dr Yogan Pillay argues it is firstly critical to agree on what we mean by ending AIDS. Secondly, he suggests it is important to have accurate and granular data that can inform a more targeted approach to reaching those people that the health system typically…

    ·

  • Analysis: Where we are with NIMART 13 years later

    Once South Africa had closed the door on state-sponsored AIDS denialism in 2008, a critical question was how to offer HIV treatment to as many eligible people as possible as quickly as possible. Given that the health system did not have enough doctors for the job, it was decided in 2010 to rope in nurses…

    ·

  • Interview: “I used that anger to feed my activist’s soul,” says former TAC General Secretary

    In 2001, at age 22, Vuyiseka Dubula-Majola joined the Treatment Action Campaign in its fight to bring antiretrovirals to South Africa. Today, she walks the streets of Geneva in Switzerland to get to her job as head of the Global Fund’s community, rights and gender department. Biénne Huisman spoke with Dubula-Majola about her remarkable journey,…

    ·

  • Integrating HIV and NCD care is critical but not straight-forward, clinicians say

    With the remarkable success of antiretroviral treatment people living with HIV in South Africa are generally living much longer than they did two decades ago. As a result, more people with HIV are also now living with non-communicable diseases (NCDs) such as diabetes and hypertension. Accordingly, the need to better integrate HIV and NCD services…

    ·

  • Opinion: SA can’t afford proposed cuts to HIV funding

    National Treasury has proposed a R1 billion cut to HIV funding. This has come about because – rather than seeing the reduced price of antiretroviral treatment as an opportunity to scale up treatment coverage and strengthen other interventions to address the HIV epidemic – the Department of Health has seen it as an opportunity for…

    ·

  • Interview: From a pig farm in Zim to star HIV researcher- Prof LGB reflects on her remarkable journey

    Inside Professor Linda-Gail Bekker’s office a bookshelf is stacked with titles on general medicine, HIV and tuberculosis. Against the bookshelf, a mannequin leans dressed in a white doctor’s coat, sparkling tiara and pink Venetian mask, with a stethoscope protruding from her pocket. Known to colleagues as LGB, Bekker is one of South Africa’s top HIV…

    ·

  • Analysis: Amid budget constraints, tough choices for SA’s HIV response

    Around 13% of South Africa’s population are living with HIV and the country has the world’s largest HIV treatment programme. The country’s finances are however under huge pressure and significant cuts were recently announced to government’s HIV budget. Catherine Tomlinson unpacks what a new HIV Investment Case can tell us about the possible paths forward.

    ·

  • How do long-acting HIV treatments work?

    Researchers have been trying to develop antiretroviral medicines that can last for weeks, months or even years per dose. Two such long-acting formulations have been approved in South Africa, but several more are on the horizon. Elri Voigt explores the science behind what makes a formulation long-acting and takes a look at some particularly exciting…

    ·